Stay updated on AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial
Sign up to get notified when there's something new on the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page.

Latest updates to the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page
- Check2 days agoChange DetectedAdded Narcolepsy as a condition and a Genetic and Rare Diseases Information Center resource; updated to Revision v3.4.2. Removed the funding-status notice and the prior revision note (v3.4.1).SummaryDifference0.4%

- Check9 days agoChange DetectedA government funding/status notice was added at the top of the page and the revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check16 days agoChange DetectedThe new page adds a 'Show glossary' option and the labels 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The previous version displayed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check31 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded a consolidated Locations section listing all study sites by state/province (Alabama, Arizona, California, Colorado, Florida, Georgia, Hawaii, Illinois, Indiana, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Texas, Virginia, Ontario). This expands core content by detailing where the trial sites are located.SummaryDifference2%

- Check80 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. This change does not appear to alter study details.SummaryDifference0.0%

Stay in the know with updates to AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page.